MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

Autor: Christine Van Broeckhoven, Isabelle Bos, Pablo Martinez-Lage, Frans R.J. Verhey, Frederik Barkhof, Alison L. Baird, Magdalini Tsolaki, Régis Bordet, Jolien Schaeverbeke, Sebastiaan Engelborghs, Pieter Jelle Visser, Olivier Blin, Zhiyong Xie, Mark Forrest Gordon, Silvy Gabel, Mara ten Kate, Carl Eckerström, Rik Vandenberghe, Jérôme Revillard, Julius Popp, Cristina Legido-Quigley, Alberto Redolfi, Giovanni B. Frisoni, Simon Lovestone, Gerald Novak, Lars Bertram, Jill C. Richardson, Johannes Streffer, Silvia Bianchetti, José Luis Molinuevo, Anders Wallin, Enrico Peira, Viktor Wottschel, Valerija Dobricic, Philip Scheltens, Henrik Zetterberg, Stephanie J.B. Vos

Publikováno v: Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-12 (2018)
Alzheimer's Research & Therapy, 10(1). BioMed Central
Alzheimer's research & therapy
Alzheimer's Research & Therapy
Alzheimer's research & therapy, vol. 10, no. 1, pp. 100
Alzheimer's Research & Therapy, 10:100. BioMed Central Ltd
Alzheimer's Research and Therapy
Alzheimer's Research and Therapy, 2018, 10 (1), pp.100. ⟨10.1186/s13195-018-0428-1⟩
Ten Kate, M, Redolfi, A, Peira, E, Bos, I, Vos, S J, Vandenberghe, R, Gabel, S, Schaeverbeke, J, Scheltens, P, Blin, O, Richardson, J C, Bordet, R, Wallin, A, Eckerstrom, C, Molinuevo, J L, Engelborghs, S, Van Broeckhoven, C, Martinez-Lage, P, Popp, J, Tsolaki, M, Verhey, F R J, Baird, A L, Legido-Quigley, C, Bertram, L, Dobricic, V, Zetterberg, H, Lovestone, S, Streffer, J, Bianchetti, S, Novak, G P, Revillard, J, Gordon, M F, Xie, Z, Wottschel, V, Frisoni, G, Visser, P J & Barkhof, F 2018, ' MRI predictors of amyloid pathology : results from the EMIF-AD Multimodal Biomarker Discovery study ', Alzheimer's Research & Therapy, vol. 10, no. 1, pp. 100 . https://doi.org/10.1186/s13195-018-0428-1
Alzheimer's Research and Therapy, Vol. 10, No 1 (2018) P. 100

Background With the shift of research focus towards the pre-dementia stage of Alzheimer’s disease (AD), there is an urgent need for reliable, non-invasive biomarkers to predict amyloid pathology. The aim of this study was to assess whether easily o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5b0f83b58949d9cc7bd2b136091eda
http://link.springer.com/article/10.1186/s13195-018-0428-1